Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-06-000904
Filing Date
2006-06-26
Accepted
2006-06-26 17:12:12
Documents
2
Group Members
DANIEL S. LOEB

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING t3304457b.txt SC 13G 15042
3 JOINT FILING AGREEMENT t3304457c.txt EX-1 2000
  Complete submission text file 0000899140-06-000904.txt   19224
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Subject) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44359 | Film No.: 06925132
SIC: 2834 Pharmaceutical Preparations

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

EIN.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G